Published in Mol Cell Biol on November 01, 2000
Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet (2013) 2.43
Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J (2007) 2.07
The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J (2002) 1.72
The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc Natl Acad Sci U S A (2003) 1.64
Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol Cell Biol (2004) 1.57
The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts. J Cell Biol (2002) 1.49
Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin. Mol Cell Biol (2004) 1.37
Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes. Mol Cell Biol (2007) 1.30
FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J Clin Invest (2005) 1.25
Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts. EMBO J (2005) 1.11
Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2. Mol Endocrinol (2006) 1.06
Sox15 and Fhl3 transcriptionally coactivate Foxk1 and regulate myogenic progenitor cells. EMBO J (2007) 1.05
Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues. J Cell Mol Med (2010) 1.01
Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells. BMC Genomics (2009) 1.00
Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism. Mol Cell Biol (2002) 0.98
The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation. J Biol Chem (2008) 0.98
Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease-9 expression in osteoblasts. Growth Horm IGF Res (2005) 0.96
Abnormal sperm in mice with targeted deletion of the act (activator of cAMP-responsive element modulator in testis) gene. Proc Natl Acad Sci U S A (2004) 0.95
Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis. Mol Biosyst (2011) 0.95
Role of basic leucine zipper proteins in transcriptional regulation of the steroidogenic acute regulatory protein gene. Mol Cell Endocrinol (2008) 0.95
Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes. Front Mol Neurosci (2013) 0.94
FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth. J Cell Mol Med (2011) 0.92
Regulation of myocardin factor protein stability by the LIM-only protein FHL2. Am J Physiol Heart Circ Physiol (2008) 0.92
Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer. BMC Genomics (2010) 0.91
Regulation of murine lactate dehydrogenase C (Ldhc) gene expression. Biol Reprod (2007) 0.91
KLF3 regulates muscle-specific gene expression and synergizes with serum response factor on KLF binding sites. Mol Cell Biol (2010) 0.90
KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2. Oncotarget (2015) 0.89
The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells. Mol Endocrinol (2012) 0.84
SLIMMER (FHL1B/KyoT3) interacts with the proapoptotic protein Siva-1 (CD27BP) and delays skeletal myoblast apoptosis. J Biol Chem (2009) 0.83
Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice. PLoS One (2010) 0.82
Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice. Calcif Tissue Int (2006) 0.82
The four and a half LIM-only protein 2 (FHL2) activates transforming growth factor β (TGF-β) signaling by regulating ubiquitination of the E3 ligase Arkadia. J Biol Chem (2012) 0.81
FHL3 negatively regulates human high-affinity IgE receptor beta-chain gene expression by acting as a transcriptional co-repressor of MZF-1. Biochem J (2005) 0.80
Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes. Biochem J (2014) 0.79
Heart failure-specific changes in protein kinase signalling. Pflugers Arch (2014) 0.78
The LIM domain protein nTRIP6 recruits the mediator complex to AP-1-regulated promoters. PLoS One (2014) 0.78
The four and a half LIM family members are novel interactants of the human T-cell leukemia virus type 1 Tax oncoprotein. J Virol (2013) 0.78
FHL2 regulates hematopoietic stem cell functions under stress conditions. Leukemia (2014) 0.77
The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways. PLoS One (2008) 0.77
Fhl5/Act, a CREM-binding transcriptional activator required for normal sperm maturation and morphology, is not essential for testicular gene expression. Reprod Biol Endocrinol (2009) 0.77
Interaction of TACC proteins with the FHL family: implications for ERK signaling. J Cell Commun Signal (2007) 0.76
Plumbagin exhibits an anti-proliferative effect in human osteosarcoma cells by downregulating FHL2 and interfering with Wnt/β-catenin signalling. Oncol Lett (2016) 0.75
The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription. Cell Death Dis (2016) 0.75
A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity. Nat Commun (2017) 0.75
Decompensation of β-cells in diabetes: when pancreatic β-cells are on ICE(R). J Diabetes Res (2014) 0.75
Four-and-a-half LIM Domains 1 (FHL1) Protein Interacts with the Rho Guanine Nucleotide Exchange Factor PLEKHG2/FLJ00018 and Regulates Cell Morphogenesis. J Biol Chem (2016) 0.75
Identification and characterization of MT-1X as a novel FHL3-binding partner. PLoS One (2014) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36
The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell (1996) 16.57
Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell (1988) 12.68
Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature (1993) 11.54
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell (1989) 11.41
The CBP co-activator is a histone acetyltransferase. Nature (1997) 10.91
Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature (1994) 9.37
The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J (1997) 6.36
Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J (1998) 5.70
Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature (1994) 5.65
Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell (1997) 5.39
Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science (1996) 4.96
Xenopus embryos regulate the nuclear localization of XMyoD. Genes Dev (1994) 4.77
MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell (1997) 4.67
CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science (1991) 4.53
Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature (1995) 4.49
A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature (1995) 4.40
CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell (1991) 4.11
RNA helicase A mediates association of CBP with RNA polymerase II. Cell (1997) 4.00
Transcriptional regulation by cyclic AMP. Annu Rev Biochem (1997) 3.81
LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet (1998) 3.63
The LIM domain is a modular protein-binding interface. Cell (1994) 3.50
TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins. Genes Dev (1997) 3.40
Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell (1994) 3.30
FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J (1996) 2.98
Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol (1996) 2.84
Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell (1993) 2.84
Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice. Nature (1996) 2.74
Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature (1996) 2.63
Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell (1994) 2.44
Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev (1988) 2.38
Characterization of motifs which are critical for activity of the cyclic AMP-responsive transcription factor CREB. Mol Cell Biol (1991) 2.27
FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J (2000) 2.25
Calendar of gametogenic development in the prepuberal male mouse. Science (1961) 2.03
Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. J Clin Invest (1998) 2.00
Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol Cell Biol (1995) 1.96
LIM protein KyoT2 negatively regulates transcription by association with the RBP-J DNA-binding protein. Mol Cell Biol (1998) 1.96
The cAMP-regulated transcription factor CREB interacts with a component of the TFIID complex. Proc Natl Acad Sci U S A (1994) 1.95
Transcription factors responsive to cAMP. Annu Rev Cell Dev Biol (1995) 1.83
CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J (1997) 1.78
LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev (1998) 1.71
Transcriptional regulation by cyclic AMP-responsive factors. Prog Nucleic Acid Res Mol Biol (2000) 1.68
Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci U S A (1998) 1.66
Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD. Mol Cell Biol (1997) 1.66
Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature (1996) 1.65
Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature (1991) 1.55
Signaling routes to CREM and CREB: plasticity in transcriptional activation. Trends Biochem Sci (1999) 1.50
CREB-binding protein activates transcription through multiple domains. J Biol Chem (1996) 1.48
Distinct activation domains within cAMP response element-binding protein (CREB) mediate basal and cAMP-stimulated transcription. J Biol Chem (1993) 1.47
Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. Gene (1998) 1.40
CBP-independent activation of CREM and CREB by the LIM-only protein ACT. Nature (1999) 1.37
The functional versatility of CREM is determined by its modular structure. EMBO J (1993) 1.32
The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells. Mol Cell Biol (1995) 1.24
Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol (1997) 1.18
Multiple and cooperative phosphorylation events regulate the CREM activator function. EMBO J (1993) 1.17
Characterization of a brain-specific nuclear LIM domain protein (FHL1B) which is an alternatively spliced variant of FHL1. Gene (1999) 1.05
Slim defines a novel family of LIM-proteins expressed in skeletal muscle. Biochem Biophys Res Commun (1996) 1.04
Chromosomal mapping, tissue distribution and cDNA sequence of four-and-a-half LIM domain protein 1 (FHL1). Gene (1998) 1.03
Transcriptional response to cAMP in brain: specific distribution and induction of CREM antagonists. Neuron (1993) 1.01
The fourth member of the FHL family of LIM proteins is expressed exclusively in the testis. Biochem Biophys Res Commun (1999) 0.95
Ectopic ICER expression in pituitary corticotroph AtT20 cells: effects on morphology, cell cycle, and hormonal production. Mol Endocrinol (1997) 0.90
Physiological role of phosphorylation of the cyclic AMP response element binding protein in rat cardiac nuclei. Cell Tissue Res (1996) 0.79
Amphioxus AmphiDRAL encoding a LIM-domain protein: expression in the epidermis but not in the presumptive neuroectoderm Mech Dev (1998) 0.79
Mechanisms of activation by CREB and CREM: phosphorylation, CBP, and a novel coactivator, ACT. Cold Spring Harb Symp Quant Biol (1998) 0.78
Promoter sequences of eukaryotic protein-coding genes. Science (1980) 19.96
A reliable method for the recovery of DNA fragments from agarose and acrylamide gels. Anal Biochem (1981) 15.38
Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell (2000) 5.79
Signaling to chromatin through histone modifications. Cell (2000) 5.36
Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature (1988) 5.18
Sequences upstream from the T-A-T-A box are required in vivo and in vitro for efficient transcription from the adenovirus serotype 2 major late promoter. Proc Natl Acad Sci U S A (1982) 4.30
Stimulation of in vitro transcription from the SV40 early promoter by the enhancer involves a specific trans-acting factor. EMBO J (1984) 4.28
CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell (1991) 4.11
A trans-acting factor is responsible for the simian virus 40 enhancer activity in vitro. Nature (1985) 4.01
Dimers, leucine zippers and DNA-binding domains. Trends Genet (1990) 3.98
c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1988) 3.24
Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature (1996) 3.21
An enhancer element is located 340 base pairs upstream from the adenovirus-2 E1A capsite. Nucleic Acids Res (1983) 3.11
Light acts directly on organs and cells in culture to set the vertebrate circadian clock. Nature (2000) 2.97
Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell (1993) 2.84
Developmental switch of CREM function during spermatogenesis: from antagonist to activator. Nature (1992) 2.78
Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice. Nature (1996) 2.74
Individual products of the adenovirus 12S and 13S EIa mRNAs stimulate viral EIIa and EIII expression at the transcriptional level. Proc Natl Acad Sci U S A (1984) 2.64
Adrenergic signals direct rhythmic expression of transcriptional repressor CREM in the pineal gland. Nature (1993) 2.61
Promotion of specific in vitro transcription by excised "TATA" box sequences inserted in a foreign nucleotide environment. Nucleic Acids Res (1981) 2.57
More is better: activators and repressors from the same gene. Cell (1992) 2.56
Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci U S A (1998) 2.50
Stimulation of in vitro transcription from heterologous promoters by the simian virus 40 enhancer. Proc Natl Acad Sci U S A (1984) 2.44
Altered behavioral rhythms and clock gene expression in mice with a targeted mutation in the Period1 gene. EMBO J (2001) 2.11
Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell (1990) 2.10
Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins. Genes Dev (1989) 2.06
Transcriptional analysis of the adenovirus-5 EIII promoter: absence of sequence specificity for stimulation by EIa gene products. Nucleic Acids Res (1985) 2.04
Proto-oncogene fos: complex but versatile regulation. Cell (1987) 1.99
IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation. Cell (1991) 1.99
Light induces chromatin modification in cells of the mammalian circadian clock. Nat Neurosci (2000) 1.98
Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol Cell Biol (1995) 1.96
Late arrest of spermiogenesis and germ cell apoptosis in mice lacking the TBP-like TLF/TRF2 gene. Mol Cell (2001) 1.94
A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products. Nature (1986) 1.93
Zebrafish Clock rhythmic expression reveals independent peripheral circadian oscillators. Nat Neurosci (1998) 1.90
DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature (1997) 1.88
A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nat Genet (1999) 1.87
Signal transduction and gene regulation: the nuclear response to cAMP. J Biol Chem (1994) 1.86
Modulation of c-fos gene transcription by negative and positive cellular factors. Nature (1987) 1.83
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation (2001) 1.72
A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Mol Cell Biol (1989) 1.70
Transcriptional regulation by cyclic AMP-responsive factors. Prog Nucleic Acid Res Mol Biol (2000) 1.68
Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell (1994) 1.67
Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci U S A (1998) 1.66
Repression of c-fos promoter by MyoD on muscle cell differentiation. Nature (1993) 1.62
Specific in vitro initiation of transcription on the adenovirus type 2 early and late EII transcription units. Proc Natl Acad Sci U S A (1981) 1.52
Signaling routes to CREM and CREB: plasticity in transcriptional activation. Trends Biochem Sci (1999) 1.50
Viral enhancer activity in teratocarcinoma cells. Cold Spring Harb Symp Quant Biol (1985) 1.49
Multilevel regulation of the circadian clock. Nat Rev Mol Cell Biol (2000) 1.48
Systemic oxidative stress and its relationship with age and illness. Associazione Medica "Sabin". J Am Geriatr Soc (1996) 1.44
Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene (1995) 1.41
Identification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes. Cell Growth Differ (1995) 1.41
Far upstream sequences are required for efficient transcription from the adenovirus-2 E1A transcription unit. Nucleic Acids Res (1983) 1.40
Alternative usage of initiation codons in mRNA encoding the cAMP-responsive-element modulator generates regulators with opposite functions. Proc Natl Acad Sci U S A (1992) 1.39
Promoter trans-activation of protooncogenes c-fos and c-myc, but not c-Ha-ras, by products of adenovirus early region 1A. Proc Natl Acad Sci U S A (1987) 1.38
CBP-independent activation of CREM and CREB by the LIM-only protein ACT. Nature (1999) 1.37
Pituitary hormone FSH directs the CREM functional switch during spermatogenesis. Nature (1993) 1.36
Positive regulation of jun/AP-1 by E1A. Mol Cell Biol (1991) 1.32
The functional versatility of CREM is determined by its modular structure. EMBO J (1993) 1.32
Induction of CREM activator proteins in spermatids: down-stream targets and implications for haploid germ cell differentiation. Mol Endocrinol (1993) 1.31
Negative regulation of Jun/AP-1: conserved function of glycogen synthase kinase 3 and the Drosophila kinase shaggy. Oncogene (1993) 1.29
Signal transduction and gene control: the cAMP pathway. Crit Rev Oncog (1992) 1.29
Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol Endocrinol (1996) 1.28
Cyclic AMP signalling. J Cell Sci (2001) 1.25
Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol Endocrinol (1996) 1.24
Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO J (1991) 1.22
Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J Biol Chem (1992) 1.22
Mitogen-regulated RSK2-CBP interaction controls their kinase and acetylase activities. Mol Cell Biol (2001) 1.21
A cell-based system that recapitulates the dynamic light-dependent regulation of the vertebrate clock. Proc Natl Acad Sci U S A (2001) 1.20
Multiple and cooperative phosphorylation events regulate the CREM activator function. EMBO J (1993) 1.17
Transcription factor CREM coordinates the timing of hepatocyte proliferation in the regenerating liver. Genes Dev (1998) 1.15
Asynchronous oscillations of two zebrafish CLOCK partners reveal differential clock control and function. Proc Natl Acad Sci U S A (2000) 1.15
Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation--a potential mechanism in atherosclerosis. J Investig Med (1999) 1.10
Hormonal control of gene expression: multiplicity and versatility of cyclic adenosine 3',5'-monophosphate-responsive nuclear regulators. Mol Endocrinol (1993) 1.08
Transcriptional regulation of the mouse steroidogenic acute regulatory protein gene by the cAMP response-element binding protein and steroidogenic factor 1. J Mol Endocrinol (2003) 1.07
Rhythmic transcription: the molecular basis of circadian melatonin synthesis. Trends Neurosci (1997) 1.07
Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron (1991) 1.04
Thyroid-stimulating hormone (TSH)-directed induction of the CREM gene in the thyroid gland participates in the long-term desensitization of the TSH receptor. Proc Natl Acad Sci U S A (1995) 1.04
Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations. Am J Hum Genet (1998) 1.03
Transcriptional control of circadian hormone synthesis via the CREM feedback loop. Proc Natl Acad Sci U S A (1996) 1.03
Two adjacent promoter elements mediate nerve growth factor activation of the c-fos gene and bind distinct nuclear complexes. Proc Natl Acad Sci U S A (1988) 1.02
Transformation and transactivation suppressor activity of the c-Jun leucine zipper fused to a bacterial repressor. Proc Natl Acad Sci U S A (1992) 1.02
A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol (1997) 1.02
Transcriptional response to cAMP in brain: specific distribution and induction of CREM antagonists. Neuron (1993) 1.01
Pituitary follicle-stimulating hormone (FSH) induces CREM gene expression in Sertoli cells: involvement in long-term desensitization of the FSH receptor. Proc Natl Acad Sci U S A (1995) 1.01
Adaptive inducibility of CREM as transcriptional memory of circadian rhythms. Nature (1996) 1.00
Activation of transcription via AP-1 or CREB regulatory sites is blocked by protein tyrosine phosphatases. Oncogene (1991) 1.00
Molecular clocks: mastering time by gene regulation. Nature (1998) 0.99
DAX-1 blocks steroid production at multiple levels. Endocrinology (1998) 0.99
Transcriptional antagonist cAMP-responsive element modulator (CREM) down-regulates c-fos cAMP-induced expression. Proc Natl Acad Sci U S A (1991) 0.98
The bacterial protein YopJ abrogates multiple signal transduction pathways that converge on the transcription factor CREB. Cell Microbiol (2000) 0.97
2 micrometer covalently closed non-mitochondrial circular DNA in the petite-negative yeast Schizosaccharomyces pombe. Mol Gen Genet (1979) 0.97
Inhibition of corticotrophin-releasing hormone transcription by inducible cAMP-early repressor in the hypothalamic cell line, 4B. J Neuroendocrinol (2006) 0.97
Chromatin remodeling and circadian control: master regulator CLOCK is an enzyme. Cold Spring Harb Symp Quant Biol (2007) 0.96
The time of metabolism: NAD+, SIRT1, and the circadian clock. Cold Spring Harb Symp Quant Biol (2011) 0.96
Signaling to chromatin through histone modifications: how clear is the signal? Cold Spring Harb Symp Quant Biol (1998) 0.96
fos and jun interaction: the role of the leucine zipper. Int J Cancer Suppl (1989) 0.95